title: Fibrin β15-42 domain is cryptic in intact fibrinogen: comment on the study by A. Sahni et al.
authors.forename: Ester M
authors.initials: EM
authors.lastname: Weijers
authors.forename: Pieter
authors.initials: P
authors.lastname: Koolwijk
authors.forename: Victor W M
authors.initials: VW
authors.lastname: van Hinsbergh
authors.forename: Geerten P
authors.initials: GP
authors.lastname: van Nieuw Amerongen
mesh_terms: D015703:Antigens, CD / Q000378:metabolism*; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology; D015820:Cadherins / Q000378:metabolism*; D002463:Cell Membrane Permeability; D002465:Cell Movement; D004730:Endothelium, Vascular / Q000166:cytology / Q000378:metabolism*; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism*; D005340:Fibrinogen / Q000378:metabolism*; D006801:Humans; D010446:Peptide Fragments / Q000378:metabolism*; D000099152:Cadherin 5
chemical_list: D015703:Antigens, CD; D015820:Cadherins; D005338:Fibrin Fibrinogen Degradation Products; D005340:Fibrinogen; D010446:Peptide Fragments; D000099152:Cadherin 5; C033786:fibrinogen Bbeta (15-42)